Differentiate your dairy portfolio with new concept from Chr. Hansen targeting the attractive consumer segment of 17-35-year-olds.
If you would like a fresh take on modern dairy desserts and welcome the opportunity to differentiate from competition, target new consumer groups and thereby grow the market, Chr. Hansen’s new Creme Delight concept may be of interest.
Combining a number of well-proven cultures and a deep insight into consumer trends Chr. Hansen has taken a new approach to fermented milks to attract “Gen Y”. This generation, born in the early 1980s to the early 2000s, is made up of a high proportion of food sophisticates who are willing to put in the effort to eat healthier and tastier foods, but who are also luxury-seeking. They are a new pool of powerful consumers, and dairy manufactures are starting to pay attention to their needs.
Deluxe alternative to yogurt – healthier than ice cream
“Creme Delight is an indulgent, yet relatively healthy snack. It is a creamy deluxe alternative to yogurt and a healthy dessert alternative to mousses and ice cream. We believe there is an opportunity within the segment of modern, young people, so we would like to bring inspiration to customers on how to offer a different kind of product and reach new consumers,” says Karsten Tjener, Sr. Marketing Manager, Chr. Hansen.
“The cultured dessert has a very mild profile compared to yogurt, which makes it ideal for introducing new flavors such as coconut, “brown flavors” (toffee, coffee, chocolate) and lemon and other fresh fruity notes,” explains Tjener who predicts a global interest in the concept.
Creme Delight is based on all-natural ingredients not requiring stabilizers and with a relatively low sugar content. The world’s most studied Bifidobacterium BB-12® ensures a healthy profile and contributes to the unique fresh taste.
“We see our new concept as an exciting expansion of the dairy shelves in supermarkets. We have presented it to a number of customers in Asia, North America and Europe where it has generated positive interest,” concludes Tjener.
Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products include cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. Revenue in the 2013/14 financial year was EUR 756 million. The company holds a leading market position in all its divisions: Cultures & Enzymes, Health & Nutrition and Natural Colors. It has more than 2,500 dedicated employees in over 30 countries and main production facilities in Denmark, France, USA and Germany. Chr. Hansen was founded in 1874 and is listed on NASDAQ OMX Copenhagen.